BBOT
BridgeBio Oncology Therapeutics, Inc.
3.40$
-1.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | +200.0% | -66.7% | +3.8% | +235.2% | +129.8% | -53.4% | -4.1% | -59.1% | – | |
| – | – | – | -95.1% | +0.0% | +0.0% | -25.2% | +1,410.7% | +223.8% | +4.0% | +31.4% | +86.7% | – | |
| – | – | – | -97.5% | +9,264.4% | -98.9% | -84.1% | +22,005.3% | +132.7% | -162.3% | – | +334.9% | – | |
| – | – | – | +0.0% | +178.6% | -74.4% | +1,520.0% | +42.6% | +130.7% | -86.3% | -67.1% | +95.8% | – | |
| – | – | – | – | – | – | – | – | +580.2% | -88.2% | -3,775.1% | – | – | |
| – | – | – | +2,902.7% | -90.1% | -99.7% | -876.9% | – | +1,925.7% | -100.2% | – | -87.5% | – | |
| – | – | – | -116.7% | – | – | – | – | +7,596.7% | -108.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.